Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
33 studies found for:    " February 18, 2013":" March 20, 2013"[FIRST-RECEIVED-DATE]AND HIV[CONDITION]
Show Display Options
RSS Create an RSS feed from your search for:
" February 18, 2013":" March 20, 2013"[FIRST-RECEIVED-DATE]AND HIV[CONDITION]
Need help? See RSS Feeds
Choose a feed type:
Show studies that were first received in the last 14 daysShow studies that were first received in the last 14 days
Show studies added or modified in the last 14 daysShow studies that were added or modified in the last 14 days
Rank Status Study
1 Active, not recruiting
Has Results
Switching From a TDF-Containing Combination Regimen to a TAF-Containing Fixed Dose Combination (FDC) in Virologically-Suppressed, HIV-1 Positive Participants
Conditions: HIV;   HIV Infections
Interventions: Drug: E/C/F/TAF;   Drug: E/C/F/TDF;   Drug: EFV/FTC/TDF;   Drug: RTV;   Drug: ATV;   Drug: FTC/TDF;   Drug: COBI
2 Completed Antiretroviral Therapy and Extreme Weight
Condition: HIV Infection
Intervention:
3 Active, not recruiting
Has Results
Study to Evaluate the Safety and Efficacy of E/C/F/TAF (Genvoya®) Versus E/C/F/TDF (Stribild®) in HIV-1 Positive, Antiretroviral Treatment-Naive Adults
Conditions: HIV;   HIV Infections
Interventions: Drug: E/C/F/TAF;   Drug: E/C/F/TDF;   Drug: E/C/F/TDF Placebo;   Drug: E/C/F/TAF Placebo
4 Completed Fluoride Metabolism, Bone Remodelling and Mineral Density in HIV Patients Treated With Tenofovir +/- Emtricitabine
Condition: HIV Seropositivity
Intervention:
5 Recruiting Trial of Vitamin D in HIV Progression
Condition: HIV Infection
Interventions: Dietary Supplement: Vitamin D3 (cholecalciferol);   Other: Placebo
6 Terminated
Has Results
A Trial Examining the Efficacy of Escitalopram Oxalate Upon Depressive Symptoms and Fatigue in HIV Seropositive Women
Conditions: Depression;   HIV
Interventions: Drug: Placebo;   Drug: Escitalopram
7 Completed Evaluating the Safety and Priming Response of an HIV Vaccine Regimen in Healthy, HIV-Uninfected Adults
Condition: HIV Infections
Interventions: Biological: DNA-HIV-PT123;   Biological: NYVAC-HIV-PT1;   Biological: NYVAC-HIV-PT4;   Biological: AIDSVAX® B/E;   Biological: Placebo for DNA/NYVAC;   Biological: Placebo for AIDSVAX(R) B/E
8 Enrolling by invitation The "START" (a Streamlined ART Initiation Strategy) Study
Condition: HIV
Intervention: Behavioral: START
9 Recruiting Intervention Research to Reduce HIV Sexual Transmission Among HIV Positive Men Who Have Sex With Men
Condition: HIV
Interventions: Behavioral: Gay Poz Sex;   Other: Wait List/Standard of Care
10 Active, not recruiting Immune Enhancement for Immunological Non-responders to ART
Condition: HIV
Intervention: Dietary Supplement: Zinc and SAMe
11 Recruiting HIV Test and Treat to Prevent HIV Transmission Among MSM and Transgender Women
Condition: HIV
Intervention: Drug: Atripla or Stribild
12 Completed Optimizing Integrated PMTCT Services in Rural North-Central Nigeria
Conditions: Suspected Damage to Fetus From Viral Disease in the Mother;   HIV
Interventions: Other: Task-shifting to lower-cadre providers at PMTCT sites;   Other: POC CD4+ cell count testing;   Other: integrated mother-infant care;   Other: Prominent role for influential family members (male partners) in collaboration with CHWs
13 Unknown  Alcohol Use and Risky Sexual Behaviors Among HIV Infected Subjects in Kampala Uganda
Conditions: Alcohol Use;   HIV
Intervention: Behavioral: Motivational intervention counselling plus SPP
14 Completed National Evaluation of PI-based 2nd Line Efficacy in Cambodia
Condition: HIV
Intervention:
15 Unknown  Social Networks and Prevention
Condition: HIV
Interventions: Behavioral: SNAP;   Behavioral: SNAP Control
16 Unknown  Impact on T Cell Immune Activation and Inflammation of Triptolide Woldifii in HIV-infected Immunological Non-responders
Condition: HIV
Interventions: Drug: Triptolide;   Drug: cART;   Drug: placebo
17 Terminated
Has Results
Quality of Life of HIV-infected Participants Switched to Raltegravir Versus Other Antiretroviral Regimens (MK-0518-266)
Condition: Human Immunodeficiency Virus
Intervention:
18 Completed HPTN 073 Black Men Who Have Sex With Men (MSM) Pre-Exposure Prophylaxis (PrEP)
Condition: HIV
Intervention: Drug: FTC/TDF
19 Completed Pharmacokinetics of Tenofovir and Tenofovir-diphosphate, Emtricitabine and Emtricitabine-triphosphate, and Rilpivirine Once Daily Over 14 Days Following Drug Intake Cessation in Healthy Volunteers
Condition: HIV
Intervention: Drug: Eviplera®
20 Completed Efficacy and Safety of Concomitant Use of Nevirapine and Rifampicin With HIV-TB
Condition: HIV/TB Co-infection
Interventions: Drug: Nevirapine;   Drug: Efavirenz

   Previous Page Studies Shown (1-20) Next Page (21-33) Show next page of results    Last Page
Study has passed its completion date and status has not been verified in more than two years.